HI

Hiron-Trade Investments & Industrial Buildings Ltd.

HRON | TA

Overview

Corporate Details

ISIN(s):
IL0001500110
LEI:
Country:
Israel
Address:
20 Ben Zvi Rd, 6816215 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Hiron develops and manufactures electronic and communication systems for defense and civilian use.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Hiron-Trade Investments & Industrial Buildings Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-06 18:40
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of May 4th 202…
Hebrew (modern) 245.6 KB
2024-10-28 18:31
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of November 10…
Hebrew (modern) 65.0 KB
2023-10-19 20:07
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of November 5t…
Hebrew (modern) 190.9 KB

Automate Your Workflow. Get a real-time feed of all Hiron-Trade Investments & Industrial Buildings Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hiron-Trade Investments & Industrial Buildings Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medicofarma Biotech Spolka Akcyjna Logo
Biotech R&D firm developing novel drugs, devices, and therapies with a focus on oncology.
Poland MDB
Medigene AG Logo
An immuno-oncology platform creating T cell receptor (TCR)-guided therapies to treat cancer.
Germany MDG1
MedinCell S.A. Logo
Develops and licenses long-acting injectable therapies using proprietary technology.
France MEDCL
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Mendus Logo
Developing immunotherapies using dendritic cells to prevent recurrence of AML & ovarian cancer.
Sweden IMMU
Merck KGaA Logo United States of America 6MK
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Modus Therapeutics Holding AB Logo
Clinical-stage biotech developing sevuparin for sepsis, septic shock, and inflammation.
Sweden MODTX
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN